Nasal insulin spray reveals Brain's role in sugar control
NCT ID NCT06295640
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how insulin in the brain influences the body's handling of sugar after a meal. About 31 healthy volunteers will drink a sugary solution and receive either insulin or a placebo via nasal spray. Researchers will measure how the body produces and uses sugar to understand the brain's role in metabolism and any differences between men and women.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
intranasal insulin spray
What this could lead to
If successful, this could reveal how the brain helps regulate blood sugar after eating, potentially guiding future treatments for metabolic disorders.
What could go wrong
This is a small, early-stage study in healthy people, so results may not apply to those with diabetes or other conditions. The intervention is short-term and not intended as a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLUCOSE METABOLISM DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Universityhospital Ulm
Ulm, 89081, Germany